OR AKIVA, Israel, April 28 (HSMN NewsFeed) — ITGI Pharmaceutical, Ltd. (TASE: ITGI) a company engaged in research, development, manufacturing and marketing of heterologous tissue covered stents, announced that the US Food and Drug Administration (FDA) has gran…
Devices, Interventional Cardiology, FDA
ITGI Medical, Over and Under, Aneugraft, Pericardium Covered Stent

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “FDA has Granted HUD (Humanitarian Use Device) Designation to ITGI’s Pericardium Covered Stents, Over and Under(R) and Aneugraft(R), for Treatment of Perforations and Dissections of Native Coronary Arteries and Saphenous Vein Grafts”
Leave a Comment